Abstract
Bicuspid aortic valve (BAV) is a common congenital heart condition that can lead to some valve-related complications, such as aortic stenosis and/or regurgitation, and is often associated with aortic root dilation. With the development and refinement of BAV repair techniques over the past three decades, surgical repair of BAV has emerged as an effective treatment option, offering symptomatic relief and improved outcomes. This review aims to summarize the current techniques, outcomes, and challenges of BAV repair, and to provide potential future perspectives in the field.
1. Introduction
Bicuspid aortic valve (BAV) is the most common congenital heart condition, occurring in 0.7%–1.4% of the general population (2–3:1 male predominance) (). Most BAV patients are asymptomatic in early life but develop some complications over time, including aortic stenosis, aortic dilation, aortic regurgitation, coarctation, endocarditis, and dissection (). Currently, BAV repair and aortic valve replacement (AVR) are the two main surgical options to treat BAV disease. AVR with biological tissue valve or mechanical valve is a conventional approach. However, a biological tissue valve only lasts about 10–18 years due to degeneration, and a mechanical valve requires lifelong anticoagulation. With the development and improvement of BAV repair techniques over the past three decades, BAV repair have achieved excellent outcomes. Many patients receive BAV repair when feasible to avoid the limitations of classical AVR. A propensity score analysis study reported that aortic valve repair had similar operative mortality (2% vs. 5%), better overall 9-year survival (87% vs. 60%), and a slightly higher reoperation rate (8% vs. 2%) compared to AVR (). Although direct comparisons between BAV repair and AVR are currently lacking, BAV repair is expected to emerge as a more attractive procedure for treating BAV disease.
2. BAV classification
Understanding the classification of BAV is crucial for surgeons to choose appropriate BAV repair procedures for different BAV condition. BAV phenotypes and BAV-associated aortopathy have been described diversely by some researchers, while a complete standard classification system was lacking for a long time before the publishment of the international consensus statement in 2021 ().
The statement summarized three types of bicuspid valves: fused BAV, 2-sinus BAV, and partial-fusion (forme fruste) BAV. The most common type is the fused BAV, with two of the three cusps fused together within three aortic sinuses, which is specifically classified into right-left cusp fusion, right non-cusp fusion, left non-cusp fusion and indeterminate phenotypes. The 2-sinus BAV has two roughly identical cusps and two aortic sinuses, including latero-lateral and antero-posterior phenotypes. The partial-fusion BAV phenotype is characterized by small (less than 50%) fusion between two cusps at the base of one commissure, forming a “mini-raphe” ().
In addition, three categories of BAV-associated aortopathy were identified in the statement: (1) The ascending phenotype with preferential dilation at the tubular ascending aorta; (2) The root phenotype that preferentially dilates at the root; (3) The extended phenotype with extended dilation of ascending or root phenotype to adjacent segments ().
3. BAV repair techniques
In 1983, Alain Carpentier initially concluded specific techniques for aortic valve repair, including commissurotomy and cusp shaving for restricted cusp motion, circular suture for annular dilation, and triangular resection for cusp prolapse. He suggested that about 80% of congenital aortic valve malformation cases were feasible. At that time, the repair techniques were recommended only as an alternative for valve replacement in children due to insufficient clinical experience, and calcified aortic valves were not applicable (). Over the past few decades, with in-depth analyses of BAV repair results, several factors that can influence the repair results have been identified, such as age, aortic root diameter, effective height, commissural orientation, the use of a pericardial patch, etc. (). The recognition of the influencing factors has led to the advancement of specific techniques and surgical strategies.
3.1. Considering aortic root
Dilation at the aortic root is common in BAV patients. Studies have found that the degree of aortic root dilation is correlated with the degree of aortic regurgitation (AR), and dimensions of the aortic annulus and the sino-tubular junction (STJ) were independent predictors of AR progression for BAV patients (, ). Moreover, patients with constant dilated aortic root after BAV repair often require reoperation due to recurrent AR (, ). With the aim of normalizing the aortic root in BAV repair, various approaches have been proposed and applied.
In early period, annuloplasty with subcommissural plication sutures first proposed by Cabrol et al. was used by many BAV repair groups to stabilize the annulus (). However, it has been abandoned by most surgeons because it does not provide durable annular stabilization consistently and is associated with repair failure (, ).
The Yacoub remodeling procedure and the David reimplantation procedure are two types of valve-sparing aortic root surgery (Figure 1). The Yacoub procedure reconstitutes the aortic root and creates three artificial sinuses of Valsalva with a tubular Dacron graft which is scalloped at one end (). Ongoing dilation of the ventriculo-aortic junction (VAJ) is a common cause of repair failure due to the lack of VAJ stabilization in this procedure. Therefore, Lansac et al. proposed to apply subvalvular external aortic prosthetic ring annuloplasty in the Yacoub remodeling procedure and showed improved results (). The David procedure reimplants the aortic valve within a Dacron graft. Both the VAJ and the STJ are stabilized while the sinuses of Valsalva are abolished (). Kerchove et al. showed that the David procedure improved valve mobility and repair durability compared with subcommissual annuloplasty or isolated cusp repair ().
Figure 1
With the experience of adding external prosthetic ring annuloplasty in the Yacoub procedure, Lansac et al. then applied the annuloplasty to cusp repair in AR only patients (sinuses of Valsalva <40 mm) (). While Schneider and colleagues thought that external ring annuloplasty could cause aortic root distortion, as relevant height discrepancy between the aortic annulus and the VAJ were found in 20%–30% of the BAV patients. Given the anatomical variations, they modified the suture annuloplasty initially proposed by Taylor et al. and applied that at the basal level of the root (–). Later analysis of the midterm results showed that suture annuloplasty significantly improved BAV repair stability compared to isolated BAV repair, and using expanded polytetrafluorethylene (PTFE) had better repair durability and minimal local complications than using braided polyester ().
The 180°-Reimplantation technique (El Khoury technique) is a modification of the David procedure. It uses a selective annuloplasty to create a symmetric valve and stabilizes the functional aortic annulus through reimplantation of the commissure at 180° at the level of the virtual basal ring and the STJ (Figure 2). Jahanyar et al. reported excellent long-term results and concluded that the technique is suitable for most BAVs except for patients with connective tissue disorders, while some very asymmetric and tricuspid aortic valve-like phenotypes can be better repaired by tricuspidization ().
Figure 2
3.2. Considering leaflet prolapse
In the past, there was no efficient way to quantify cusp geometry until Schäfers et al. introduced the concept of “effective height” and designed a specific caliper for the identification of prolapsing leaflet and the evaluation of prolapse correction outcomes (). However, the measurement of effective height is only applied in nonfused cusps and as reference for fused cusps because the geometric determinants of effective height are variable in fused cusps, especially the aortic insertion (). The normal range of effective height in a bicuspid valve is 9–10 mm (). Nonfused cusp with an effective height less than 9 mm is considered as prolapse and require surgical correction (, ). Currently, free margin plication and resuspension are common techniques used for correcting prolapse. The free margin plication technique is highly effective in addressing minor discrepancy in leaflet lengths, while the free margin resuspension technique is particularly useful for prolapsed cusps with fragile free margin or fenestration ().
3.3. Considering commissural orientation
Commissural angle has great influence on BAV repair durability. A commissural orientation of 160°–180° is associated with good repair durability (). Several techniques have been applied to reposition commissures. Kari et al. analysed the outcomes of BAV patients undergone valve-sparing aortic root replacement and found that commissural orientation increased in patients with no or single raphe (). Schneider et al. proposed a method to modify commissural orientation by plicating the fused sinuses and showed improved repair stability (). Later, Urbanski and colleagues developed a modified remodeling technique to achieve symmetric 180° commissural orientation by enlarging the unfused sinus with a patch and narrowing the aortic root wall on the opposite side, which is simple and effective ().
3.4. Considering the use of pericardial patch
Pericardial patch has been widely used in aortic valve repair, especially for the augmentation of retracted cusps, cusp reconstruction after triangular resection in the presence of severe calcification, and the closure of endocarditic perforations (). Karliova et al. reported that the use of pericardial patch in BAV repair increased the reoperation rate regardless of cusp pathology and repair technique, while reliable long-term competence of reconstructed BAVs following pericardial patch augmentation was achieved by Doss et al. with the principle of retaining the bicuspid morphology of the incompetent valve, enhancing the free edge of the fused leaflet with a strip of glutaraldehyde-fixed pericardium, creating large coaptation, and restoring the belly shape of the fused leaflet for optimal stress distribution (–). Therefore, when considering the use of pericardial patch in BAV repair, it is important to seriously evaluate valve morphology and cusp pathology, and formulate an appropriate surgical plan to achieve good results.
4. BAV repair outcomes
With the development and refinement of BAV repair techniques over the past few decades, bicuspid aortic valve repair has yielded promising outcomes. Svensson et al. evaluated the long-term outcomes of BAV repair with a mean follow-up of 9 years. A total of 728 patients underwent BAV repair at Cleveland Clinic with an average age of 42 were included. The results indicated that BAV repair is a safe and durable procedure, with low rates of hospital mortality (0.41%) and stroke (0.27%). The long-term survival rate at 10 years was reported to be 94%. The risk of reoperation decreased significantly, at a rate of approximately 2.6% per year, over a period of up to 15 years. The primary reasons for reoperation were identified as cusp prolapse (38%), aortic stenosis or regurgitation (17%), and aortic regurgitation resulting from a root aneurysm (15%) (). In a more recent study, Arnaoutakis et al. conducted a pooled analysis of the results from 26 studies on BAV repair, which further supported the acceptable long-term outcomes achieved through this procedure (). However, several crucial factors should be considered in order to achieve satisfactory outcomes. First, surgical expertise and experience are crucial. Experienced surgeons who have performed large amounts of BAV repair procedures tend to have better outcomes. Second, meticulous patient selection is essential for selecting the most appropriate surgical strategy, including patient general characteristics, valve morphology, valve function, and associated aortic pathology. Also, postoperative management and regular follow-up play important roles in monitoring valve function and detecting any potential complications early.
5. Challenges
Despite the advancements in BAV repair techniques, there are still some challenges and issues need to be addressed. First, a standardized approach to patient selection and surgical techniques is lacking, leading to variations in outcomes across different centers. Establishing consensus guidelines and protocols can help standardize surgical practice and improve outcomes. Second, although the positive outcomes of BAV repair have been reported in existing literatures, most studies are retrospective in nature, with varying sample sizes and follow-up durations. Prospective studies comparing different surgical techniques and approaches with consistent control of confounding predictors are necessary to provide more robust evidence. Moreover, studies assessing patients' quality of life and functional outcomes are insufficient. Dedicated studies with larger cohorts and standardized outcome assessment are necessary to further enhance our understanding about the benifits of BAV repair.
6. Future perspectives
6.1. Minimally invasive approaches
In recent years, minimally invasive approaches have been applied broadly in cardiac surgeries due to potential advantages of reduced surgical trauma and rapid recovery (–). The early post-operative results of valve-sparing David procedure via minimally invasive access have been reported to be comparable to those via full sternotomy (). In the future, minimally invasive approaches are expected to applied to a variety of BAV repair strategies, and adequate follow-up studies are needed to assess the effectiveness.
6.2. Emerging technologies
Emerging technologies are expected to enhance the precision and effectiveness of BAV repair. The application of three-dimensional (3D) printing and virtual surgical planning, especially in uncommon and high-risk situation, can help surgeons create patient-specific models and simulate complex procedures preoperatively, thereby improving surgical accuracy and reducing operative time (). Additionally, the use of advanced imaging, such as transesophageal echocardiography (TEE) and four-dimensional cardiovascular magnetic resonance flow imaging (4D Flow CMR), can provide detailed and accurate evaluation of BAVs, leading to better surgical planning and outcomes (). Further studies are needed to validate the utility of the technologies in BAV repair and their impact on the outcomes.
6.3. BAV-related genetics
BAV has been demonstrated to have a significant genetic basis (). Some genes associated with BAV development have been identified, such as NOTCH1, SMAD6, GATA4, GATA5, GATA6, ROBO4, etc. (–). However, the exact pathogenesis of BAV is not fully understood. Understanding the genetic and epigenetic underpinnings of BAV can provide insights into disease mechanisms, guide the identification of potential therapeutic targets, promote the development of novel personalized management strategies and achieve individual risk stratification with the help of genetic testing to avoid unnecessary interventions for low-risk patients and prevent potentially fatal complications early for high-risk patients (). Therefore, it is crucial to further discover and validate BAV-related clinical and genetic markers. Furthermore, their impact on surgical decision-making and clinical outcomes should be evaluated.
6.4. Multidisciplinary collaboration
Advancing the field of BAV repair also requires in-depth multidisciplinary effort. Collaboration between cardiac surgeons, cardiologists, geneticists, and imaging specialists can provide more comprehensive patient evaluation, optimal surgical planning, and sufficient follow-up. Moreover, valuable data regarding surgical outcomes, complications, and long-term durability can be shared through international databases. These collaborative efforts help identify areas for improvement, refine surgical techniques, and provide directions for future research.
7. Conclusion
BAV repair techniques have evolved significantly over the past three decades. Continued research and advancements in surgical techniques, emerging technologies, BAV-related genetics, and collaborative research are expected to further improve the outcomes of BAV repair, ultimately activating the full potential of BAV repair and provide personalized and effective treatment for individuals with BAV.
Statements
Author contributions
HZ: Writing – original draft, Writing – review & editing.
Funding
The author declares that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
Rodríguez-PalomaresJFDux-SantoyLGualaAGalian-GayLEvangelistaA. Mechanisms of aortic dilation in patients with bicuspid aortic valve: JACC state-of-the-art review. J Am Coll Cardiol. (2023) 82(5):448–64. 10.1016/J.JACC.2022.10.042
2.
SakellaropoulosSMohammedMSvabSLekaditiDSakellaropoulosPMitsisA. Causes, diagnosis, risk stratification and treatment of bicuspid aortic valve disease: an updated review. Cardiol Res. (2020) 11(4):205–12. 10.14740/CR1061
3.
MeesterCDPasquetAGerberBLVancraeynestDNoirhommePKhouryGEet alValve repair improves the outcome of surgery for chronic severe aortic regurgitation: a propensity score analysis. J Thorac Cardiovasc Surg. (2014) 148(5):1913–20. 10.1016/j.jtcvs.2014.02.010
4.
MichelenaHIDella CorteAEvangelistaAMaleszewskiJJEdwardsWDRomanMJet alInternational consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. Eur J Cardiothorac Surg. (2021) 60(3):448–76. 10.1093/ejcts/ezab038
5.
CarpentierA. Cardiac valve surgery-the “French correction”. J Thorac Cardiovasc Surg. (1983) 86(3):323–37. 10.1016/S0022-5223(19)39144-5
6.
AicherDKuniharaTIssaOABrittnerBGräberSSchäfersHJ. Valve configuration determines long-term results after repair of the bicuspid aortic valve. Circulation. (2011) 123(2):178–85. 10.1161/CIRCULATIONAHA.109.934679
7.
YangLTPellikkaPAEnriquez-SaranoMMaaloufJFScottCGMichelenaHI. Stage B aortic regurgitation in bicuspid aortic valve: new observations on progression rate and predictors. JACC Cardiovasc Imaging. (2020) 13(6):1442–5. 10.1016/j.jcmg.2020.01.012
8.
LansacEDi CentaIBonnetNLeprincePRamaAAcarCet alAortic prosthetic ring annuloplasty: a useful adjunct to a standardized aortic valve-sparing procedure?Eur J Cardiothorac Surg. (2006) 29(4):537–44. 10.1016/J.EJCTS.2005.12.055
9.
CabrolCCabrolAGuiraudonGBertrandM. Le traitement de l'insuffisance aortique par l'annuloplastie aortique [Treatment of aortic insufficiency by means of aortic annuloplasty]. Arch Mal Coeur Vaiss. (1966) 59(9):1305–12. PMID: .
10.
FederspielJMEhrlichTAbelnKSchäfersHJ. Aortic annuloplasty: subcommissural, intra-annular suture techniques, external and internal rings. JTCVS Tech. (2021) 7:98–102. 10.1016/j.xjtc.2020.12.044
11.
YacoubM. Valve-conserving operation for aortic root aneurysm or dissection. Oper Tech Thorac Cardiovasc Surg. (1996) 1(1):57–67. 10.1016/s1085-5637(07)70081-5
12.
DavidTEFeindelCM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg. (1992) 103(4):617–21; discussion 622. 10.1016/s0022-5223(19)34942-6
13.
DavidTE. Aortic valve sparing in different aortic valve and aortic root conditions. J Am Coll Cardiol. (2016) 68(6):654–64. 10.1016/j.jacc.2016.04.062
14.
KerchoveLDBoodhwaniMGlineurDVandyckMVanoverscheldeJLNoirhommePet alValve sparing-root replacement with the reimplantation technique to increase the durability of bicuspid aortic valve repair. J Thorac Cardiovasc Surg. (2011) 142(6):1430–8. 10.1016/j.jtcvs.2011.08.021
15.
LansacECentaIDCrozatEABouchotODoguetFDarocaTet alAn external open ring for isolated aortic valve repair. Multimed Man Cardiothorac Surg. (2011) 2011(214):mmcts.2009.004119. 10.1510/mmcts.2009.004119
16.
AicherDSchneiderUSchmiedWKuniharaTTochiiMSchäfersHJ. Early results with annular support in reconstruction of the bicuspid aortic valve. J Thorac Cardiovasc Surg. (2013) 145(3 Suppl):S30–4. 10.1016/j.jtcvs.2012.11.059
17.
TaylorWJThrowerWBBlackHHarkenDE. The surgical correction of aortic insufficiency by circumclusion. J Thorac Surg. (1958) 35(2):192–205. 10.1016/s0096-5588(20)30272-5
18.
SchneiderUHofmannCAicherDTakahashiHMiuraYSchäfersHJ. Suture annuloplasty significantly improves the durability of bicuspid aortic valve repair. Ann Thorac Surg (2017) 103(2):504–10. 10.1016/j.athoracsur.2016.06.072
19.
JahanyarJde KerchoveLEl KhouryG. Bicuspid aortic valve repair: the 180°-reimplantation technique. Ann Cardiothorac Surg. (2022) 11(4):473–81. 10.21037/ACS-2022-BAV-18
20.
SchäfersHJBierbachBAicherD. A new approach to the assessment of aortic cusp geometry. J Thorac Cardiovasc Surg. (2006) 132(2):436–8. 10.1016/j.jtcvs.2006.04.032
21.
EhrlichTde KerchoveLVojacekJBoodhwaniMEl-HamamsyIDe PaulisRet alState-of-the art bicuspid aortic valve repair in 2020. Prog Cardiovasc Dis. (2020) 63(4):457–64. 10.1016/j.pcad.2020.04.010
22.
BierbachBOAicherDIssaOABombergHGräberSGlombitzaPet alAortic root and cusp configuration determine aortic valve function. Eur J Cardiothorac Surg. (2010) 38(4):400–6. 10.1016/j.ejcts.2010.01.060
23.
ZhuYWooYJ. Cusp repair techniques in bicuspid and tricuspid aortic valves. JTCVS Tech. (2021) 7:109–16. 10.1016/J.XJTC.2021.01.029
24.
KariFAKvittingJPEStephensEHLiangDHMerkDRFischbeinMPet alTirone david procedure for bicuspid aortic valve disease: impact of root geometry and valve type on mid-term outcomes. Interact Cardiovasc Thorac Surg. (2014) 19(3):375–81; discussion 381. 10.1093/icvts/ivu123
25.
UrbanskiPP. Repair of bicuspid aortic valve: simple and effective achievement of symmetric valve orientation. J Thorac Cardiovasc Surg. (2020) 159(1):e33–6. 10.1016/j.jtcvs.2019.05.033
26.
DossMMoidRWoodJPMiskovicAMartensSMoritzA. Pericardial patch augmentation for reconstruction of incompetent bicuspid aortic valves. Ann Thorac Surg. (2005) 80(1):304–7. 10.1016/j.athoracsur.2004.08.038
27.
KarliovaISchneiderUEhrlichTSchäfersHJ. Results of pericardial patches in tricuspid and bicuspid aortic cusp repair. Ann Thorac Surg. (2020) 109(3):728–35. 10.1016/j.athoracsur.2019.07.025
28.
ThudtMPapadopoulosNMonsefiNMiskovicAKarimian-TabriziAZiererAet alLong-term results following pericardial patch augmentation for incompetent bicuspid aortic valves: a single center experience. Ann Thorac Surg. (2017) 103(4):1186–92. 10.1016/j.athoracsur.2016.08.082
29.
SvenssonLGAl KindiAHVivacquaAPetterssonGBMarc GillinovAMihaljevicTet alLong-term durability of bicuspid aortic valve repair. Ann Thorac Surg. (2014) 97(5):1539–48; discussion 1548. 10.1016/j.athoracsur.2013.11.036
30.
ArnaoutakisGJSultanISikiMBavariaJE. Bicuspid aortic valve repair: systematic review on long-term outcomes. Ann Cardiothorac Surg. (2019) 8(3):302–12. 10.21037/ACS.2019.05.08
31.
ShresthaMKaufeldTShresthaPMartensARustumSRudolphLet alValve-sparing david procedure via minimally invasive access does not compromise outcome. Front Cardiovasc Med. (2022) 9:966126. 10.3389/fcvm.2022.966126
32.
ChengDCHMartinJLalADiegelerAFolliguetTAWiley NifongLet alMinimally invasive versus conventional open mitral valve surgery: a meta-analysis and systematic review. Innovations (Phila). (2011) 6(2):84–103. 10.1097/IMI.0b013e3182167feb
33.
BakirICasselmanFPWellensFJeanmartHDe GeestRDegrieckIet alMinimally invasive versus standard approach aortic valve replacement: a study in 506 patients. Ann Thorac Surg. (2006) 81(5):1599–604. 10.1016/j.athoracsur.2005.12.011
34.
MontanhesiPKCoelhoGFudaba CurcioSAPoffoR. Three-dimensional printing in minimally invasive cardiac surgery: optimizing surgical planning and education with life-like models. Braz J Cardiovasc Surg. (2022) 37(1):110–7. 10.21470/1678-9741-2020-0409
35.
MarklMKilnerPJEbbersT. Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. (2011)13(1):7. 10.1186/1532-429X-13-7
36.
CripeLAndelfingerGMartinLJShoonerKWoodrow BensonD. Bicuspid aortic valve is heritable. J Am Coll Cardiol. (2004) 44(1):138–43. 10.1016/j.jacc.2004.03.050
37.
GouldRAAzizHWoodsCESeman-SenderosMASparksEPreussCet alROBO4 variants predispose individuals to bicuspid aortic valve and thoracic aortic aneurysm. Nat Genet. (2019) 51(1):42–50. 10.1038/s41588-018-0265-y
38.
XuYJDiRMQiaoQLiXMHuangRTXueSet alGATA6 loss-of-function mutation contributes to congenital bicuspid aortic valve. Gene. (2018) 663:115–20. 10.1016/j.gene.2018.04.018
39.
ShiLMTaoJWQiuXBWangJYuanFXuLet alGATA5 loss-of-Function mutations associated with congenital bicuspid aortic valve. Int J Mol Med. (2014) 33(5):1219–26. 10.3892/ijmm.2014.1700
40.
LiRGXuYJWangJLiuXYYuanFHuangRTet alGATA4 loss-of-function mutation and the congenitally bicuspid aortic valve. Am J Cardiol. (2018) 121(4):469–74. 10.1016/j.amjcard.2017.11.012
41.
GillisEKumarAALuyckxIPreussCCannaertsEvan de BeekGet alCandidate gene resequencing in a large bicuspid aortic valve-associated thoracic aortic aneurysm cohort: SMAD6 as an important contributor. Front Physiol. (2017) 8:400. 10.3389/fphys.2017.00400
42.
GargVMuthANRansomJFSchlutermanMKBarnesRKingINet alMutations in NOTCH1 cause aortic valve disease. Nature. (2005) 437(7056):270–4. 10.1038/nature03940
43.
BalistreriCRCavarrettaESciarrettaSFratiG. Light on the molecular and cellular mechanisms of bicuspid aortic valve to unveil phenotypic heterogeneity. J Mol Cell Cardiol. (2019) 133:113–4. 10.1016/j.yjmcc.2019.06.004
Summary
Keywords
bicuspid aortic valve repair, aortic surgery, aortopathy, aortic regurgitation, congenital valve disease
Citation
Zhang H (2024) Bicuspid aortic valve repair—current techniques, outcomes, challenges, and future perspectives. Front. Cardiovasc. Med. 10:1295146. doi: 10.3389/fcvm.2023.1295146
Received
15 September 2023
Accepted
23 November 2023
Published
03 January 2024
Volume
10 - 2023
Edited by
Leonard Y. Lee, The State University of New Jersey, United States
Reviewed by
Marta Bargagna, San Raffaele Hospital (IRCCS), Italy
Updates
Copyright
© 2024 Zhang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Haiyu Zhang harrychangjoe@gmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.